Your AI-Trained Oncology Knowledge Connection!

Manjeet Chadha, MD

home / authors / manjeet-chadha-md

Articles

ACR Appropriateness Criteria® Ductal Carcinoma in Situ

Seth A. Kaufman, MD;Eleanor E. R. Harris, MD;Lisa Bailey, MD;Manjeet Chadha, MD;Sharon C. Dutton, MD;Gary M. Freedman, MD;Sharad Goyal, MD;Michele Y. Halyard, MD;Kathleen C. Horst, MD;Kristina L. M. Novick, MD;Catherine C. Park, MD;W. Warren Suh, MD;Deborah Toppmeyer, MD;Jennifer Zook, MD;Bruce G. Haffty, MD

June 15th 2015

Management of ductal carcinoma in situ (DCIS) commonly involves excision, radiotherapy, and hormonal therapy. Radiotherapy is employed for local control in breast conservation. Evidence is evolving for several radiotherapy techniques exist beyond standard whole-breast irradiation.

Managing a Small Recurrence in the Previously Irradiated Breast

Manjeet Chadha, MD;Mark Trombetta, MD;Susan Boolbol, MD;Michael P. Osborne, MD, MSurg, FRCS, FACS

October 23rd 2009

Breast cancer is the most common newly diagnosed malignancy among American women. In 2008, an estimated 182,460 new cases of invasive breast cancer, and an additional 67,770 cases of in situ cancer were diagnosed. Approximately 40,480 women will die from breast cancer each year.

Is Axillary Dissection Always Indicated in Invasive Breast Cancer?

Manjeet Chadha, MD;Deborah Axelrod, MD

October 1st 1997

In light of the changing trends in the diagnosis and management of invasive breast cancer, the practice of routine axillary dissection should be reevaluated. A growing number of patients with breast cancer are diagnosed as